Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor Angiogenesis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01983085
What this trial is testing

Nitric Oxide Generating Gel Dressing in Patients With Superficial Partial Thickness Wounds

Who this might be right for
Superficial Partial Thickness BurnSkin Graft; Complications
Edixomed Ltd 13
Post-approval studies (Phase 4)Study completedNCT04813913
What this trial is testing

VASCular Impact of Angiogenic Treatment in Patients With Advanced Colorectal Cancer

Who this might be right for
Oncology
University Hospital, Rouen 13
Not applicableStudy completedNCT06472427
What this trial is testing

The Effect of Butanediol Ingestion on Skeletal Muscle Angiogenesis in Hypoxia

Who this might be right for
KetosisHypoxiaAngiogenesis
KU Leuven 15
Testing effectiveness (Phase 2)UnknownNCT02331927
What this trial is testing

PERMAD: Personalized Marker-driven Early Switch to Aflibercept in Patients With Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
University of Ulm 150
Testing effectiveness (Phase 2)UnknownNCT03267654
What this trial is testing

Gefitinib With Chemotherapy or Anti-angiogenesis in NSCLC Patients With Bim Deletion or Low EGFR Mutation Abundance

Who this might be right for
Non-small-cell Lung Cancer
Qilu Pharmaceutical Co., Ltd. 100
Post-approval studies (Phase 4)Study completedNCT00625950
What this trial is testing

Endometriosis Patients Undergoing Quinagolide Treatment

Who this might be right for
HyperprolactinemiaEndometriosis
Instituto Valenciano de Infertilidad, IVI VALENCIA 5
Testing effectiveness (Phase 2)Study completedNCT00083382
What this trial is testing

Combination Bisphosphonate and Anti-Angiogenesis Therapy With Pamidronate and Thalidomide

Who this might be right for
Multiple Myeloma
University of Arkansas 83
Early research (Phase 1)Study completedNCT01468324
What this trial is testing

AZD7451 for Recurrent Gliomas

Who this might be right for
Glioblastoma Multiforme
National Cancer Institute (NCI) 14
Testing effectiveness (Phase 2)Looking for participantsNCT07025174
What this trial is testing

Sequential Anti-Angiogenic Therapy After Immunotherapy in Advanced Biliary Tract Cancer

Who this might be right for
Bile Duct CarcinomaGall Bladder CancerBiliary Tract Cancer+1 more
First Affiliated Hospital of Zhejiang University 60
Not applicableUnknownNCT00716287
What this trial is testing

Characterisation of Gene Variants in the Angiogenic Pathway

Who this might be right for
Solid Tumors
National University Hospital, Singapore
Not applicableStudy completedNCT00247923
What this trial is testing

Endometrial Polyps: Pathophysiology and Clinical Consequences

Who this might be right for
Endometrial PolypEndometrial Cancer
Ullevaal University Hospital 1,186
Early research (Phase 1)Study completedNCT01514123
What this trial is testing

Study of VGX-100 Administered Alone and Co-administered With Bevacizumab in Adult Subjects With Advanced Solid Tumors

Who this might be right for
NeoplasmsCancer
Circadian Technologies Ltd. 43
Testing effectiveness (Phase 2)Study completedNCT01354431
What this trial is testing

BMS-936558 (MDX-1106) In Subjects With Advanced/Metastatic Clear-Cell Renal Cell Carcinoma (RCC)

Who this might be right for
Renal Cell Carcinoma
Bristol-Myers Squibb 168
Early research (Phase 1)Study completedNCT00619424
What this trial is testing

A Phase I Study Of Pazopanib With Either Erlotinib Or Pemetrexed In Patients With Advanced Solid Tumors

Who this might be right for
Lung Cancer, Non-Small Cell
GlaxoSmithKline 58
Early research (Phase 1)Study completedNCT00874588
What this trial is testing

Peptide Vaccine Targeting to Cancer Specific Antigen Combined With Anti-angiogenic Peptide Antigen in Treating Patients With Non-small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Fukushima Medical University 6
Testing effectiveness (Phase 2)Study completedNCT00577122
What this trial is testing

Medroxyprogesterone +/- Cyclophosphamide & Methotrexate in Hormone Receptor-Negative Recurrent/Metastatic Breast Cancer

Who this might be right for
Estrogen Receptor-negative Breast CancerProgesterone Receptor-negative Breast CancerRecurrent Breast Cancer+1 more
Indiana University 30
Not applicableWithdrawnNCT01977586
What this trial is testing

Functional Imaging in the Assessment of mRCC Response to Sunitinib

Who this might be right for
Metastatic Renal Cell Carcinoma
Imperial College Healthcare NHS Trust
Testing effectiveness (Phase 2)Study completedNCT00226005
What this trial is testing

PTK787 in Patients With Advanced Metastatic Pancreatic Adenocarcinoma

Who this might be right for
Neoplasm
Pancreatic Cancer Research Team 67
Testing effectiveness (Phase 2)Study completedNCT00083707
What this trial is testing

Anti-Angiogenesis Therapy Using Thalidomide in Patients With Waldenstrom's Macroglobulinemia

Who this might be right for
Waldenstrom Macroglobulinemia
University of Arkansas 40
Early research (Phase 1)Ended earlyNCT00704821
What this trial is testing

PTC299 for Treatment of Advanced Cancer

Who this might be right for
Advanced Cancer
PTC Therapeutics 76
Next Page